These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 32033477)

  • 1. Defeating Antibiotic-Resistant Bacteria: Exploring Alternative Therapies for a Post-Antibiotic Era.
    Wang CH; Hsieh YH; Powers ZM; Kao CY
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32033477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to Overcome Antimicrobial Resistance (AMR) Making Use of Non-Essential Target Inhibitors: A Review.
    Annunziato G
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections.
    Soo VW; Kwan BW; Quezada H; Castillo-Juárez I; Pérez-Eretza B; García-Contreras SJ; Martínez-Vázquez M; Wood TK; García-Contreras R
    Curr Top Med Chem; 2017; 17(10):1157-1176. PubMed ID: 27697046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
    Konreddy AK; Rani GU; Lee K; Choi Y
    Curr Med Chem; 2019; 26(28):5363-5388. PubMed ID: 29984648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-antibiotic treatment for infectious diseases.
    Ruiz J; Castro I; Calabuig E; Salavert M
    Rev Esp Quimioter; 2017 Sep; 30 Suppl 1():66-71. PubMed ID: 28882020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic resistant bacteria: current situation and treatment options to accelerate the development of a new antimicrobial arsenal.
    Tarín-Pelló A; Suay-García B; Pérez-Gracia MT
    Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1095-1108. PubMed ID: 35576494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ancient solution to a modern problem.
    Davies JE; Behroozian S
    Mol Microbiol; 2020 Mar; 113(3):546-549. PubMed ID: 32185831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel antimicrobial agents for combating antibiotic-resistant bacteria.
    Chang RYK; Nang SC; Chan HK; Li J
    Adv Drug Deliv Rev; 2022 Aug; 187():114378. PubMed ID: 35671882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Antibacterial Activity of Metal Complexes Containing 1,10- phenanthroline: Potential as Alternative Therapeutics in the Era of Antibiotic Resistance.
    Viganor L; Howe O; McCarron P; McCann M; Devereux M
    Curr Top Med Chem; 2017; 17(11):1280-1302. PubMed ID: 27697043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-virulence strategies to combat bacteria-mediated disease.
    Rasko DA; Sperandio V
    Nat Rev Drug Discov; 2010 Feb; 9(2):117-28. PubMed ID: 20081869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance.
    Frieri M; Kumar K; Boutin A
    J Infect Public Health; 2017; 10(4):369-378. PubMed ID: 27616769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug repurposing for next-generation combination therapies against multidrug-resistant bacteria.
    Liu Y; Tong Z; Shi J; Li R; Upton M; Wang Z
    Theranostics; 2021; 11(10):4910-4928. PubMed ID: 33754035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic strategies to combat antibiotic resistance.
    Brooks BD; Brooks AE
    Adv Drug Deliv Rev; 2014 Nov; 78():14-27. PubMed ID: 25450262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic Adjuvants: Rescuing Antibiotics from Resistance.
    Wright GD
    Trends Microbiol; 2016 Nov; 24(11):862-871. PubMed ID: 27430191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-virulence Strategies to Target Bacterial Infections.
    Mühlen S; Dersch P
    Curr Top Microbiol Immunol; 2016; 398():147-183. PubMed ID: 26942418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug-Resistant Bacteria and Alternative Methods to Control Them: An Overview.
    Vivas R; Barbosa AAT; Dolabela SS; Jain S
    Microb Drug Resist; 2019; 25(6):890-908. PubMed ID: 30811275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial fitness shapes the population dynamics of antibiotic-resistant and -susceptible bacteria in a model of combined antibiotic and anti-virulence treatment.
    Ternent L; Dyson RJ; Krachler AM; Jabbari S
    J Theor Biol; 2015 May; 372():1-11. PubMed ID: 25701634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial signaling as an antimicrobial target.
    Ellermann M; Sperandio V
    Curr Opin Microbiol; 2020 Oct; 57():78-86. PubMed ID: 32916624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug combinations: a strategy to extend the life of antibiotics in the 21st century.
    Tyers M; Wright GD
    Nat Rev Microbiol; 2019 Mar; 17(3):141-155. PubMed ID: 30683887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Treatment Options in a Post-antibiotic Era.
    Bragg RR; Meyburgh CM; Lee JY; Coetzee M
    Adv Exp Med Biol; 2018; 1052():51-61. PubMed ID: 29785480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.